Developing a framework for assessing chemical respiratory sensitization: A workshop report

Regulatory Toxicology and Pharmacology

Volumn 80, Issue , 2016, Pages 295-309

  North, Colin M ^a   Ezendam, Janine ^b   Hotchkiss, Jon A ^c   Maier, Curtis ^d   Aoyama, Kohji ^e   Enoch, Steve ^f   Goetz, Amber ^g   Graham, Cynthia ^h   Kimber, Ian ⁱ   Karjalainen, Antti ^j   Pauluhn, Juergen ^k   Roggen, Erwin L ^l   Selgrade, MaryJane ^m   Tarlo, Susan M ⁿ   Chen, Connie L ^o  

^a EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c DOW CHEMICAL COMPANY   (United States)

^d GLAXOSMITHKLINE   (United States)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^g SYNGENTA CROP PROTECTION   (United States)

^h Hunstman LLC   (United States)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j EUROPEAN CHEMICALS AGENCY   (Finland)

^k BAYER PHARMA AG   (Germany)

^l 3RS MANAGEMENT AND CONSULTING APS   (Denmark)

^m ICF INTERNATIONAL   (United States)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

more..

Author keywords

Framework; Hazard identification; Inhalation; In vitro; In vivo; Respiratory sensitization; Sensitization; Skin; Tiered approach; Workshop report

Indexed keywords

AEROSOL; ANTIBODY DETECTION; ARTICLE; BIOAVAILABILITY; CHEMICAL ANALYSIS; CONCEPTUAL FRAMEWORK; DOSIMETRY; ELECTROPHILICITY; GENE EXPRESSION PROFILING; HEALTH HAZARD; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOSURVEILLANCE; LUNG TOXICITY; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; OCCUPATIONAL ASTHMA; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; RESPIRATORY SYSTEM; RESPIRATORY TRACT ALLERGY; SENSITIZATION; TH2 CELL; TRANSCRIPTOMICS; WORKSHOP; ADVERSE EFFECTS; ANIMAL; ANIMAL TESTING ALTERNATIVE; CHEMICALLY INDUCED; DERMATITIS, ALLERGIC CONTACT; DRUG EFFECTS; EXPOSURE; GENETICS; IMMUNOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; TOXICITY TESTING; TOXICOGENETICS;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ASTHMA, OCCUPATIONAL; DERMATITIS, ALLERGIC CONTACT; HUMANS; INHALATION EXPOSURE; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYSTEM; RISK ASSESSMENT; TH2 CELLS; TOXICITY TESTS; TOXICOGENETICS;

EID: 84989958229     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2016.06.006     Document Type: Article

References (84)

1. Adenuga, D., et al. Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay. Toxicol. Sci. 126 (2012), 413–425.
2. Adler, S., et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 85 (2011), 367–485.
3. Agius, R.M., et al. Structure activity hypotheses in occupational asthma caused by low molecular weight substances. Ann. Occup. Hyg. 35 (1991), 129–137.
4. Albrekt, A.S., et al. Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency. BMC Pharmacol. Toxicol., 15, 2014, 5.
5. Aleksic, M., et al. Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicol In Vitro 21 (2007), 723–733.
6. Ankley, G.T., et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29 (2010), 730–741.
7. Arts, J.H., et al. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol. Sci. 106 (2008), 423–434.
8. Ashikaga, T., et al. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern. Lab. Anim. 38 (2010), 275–284.
9. Balmes, J., et al. American thoracic society statement: occupational contribution to the burden of airway disease. Am. J. Respir. Crit. Care Med. 167 (2003), 787–797.
10. Basketter, D., Kimber, I., 5.21 - Contact hypersensitivity., second ed. McQueen, C.A., (eds.) Comprehensive Toxicology, vol. 5, 2010, Elsevier, Kidlington, 397–411.
11. Basketter, D., et al. Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern. Lab. Anim. 35 (2007), 137–154.
12. Baur, X., A compendium of causative agents of occupational asthma. J. Occup. Med. Toxicol., 8, 2013, 15.
13. Baur, X., Bakehe, P., Allergens causing occupational asthma: an evidence-based evaluation of the literature. Int. Arch. Occup. Environ. Health 87:4 (2014), 339–363.
14. Berg, N., et al. Toxicology in the 21st century–working our way towards a visionary reality. Toxicol In Vitro 25 (2011), 874–881.
15. Bernstein, I.L., et al. Definition and Classification of Asthma in the Workplace. Asthma in the Workplace. fourth ed., 2013, CRC Press - Taylor & Francis Group.
16. Boverhof, D.R., et al. Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA). Toxicol. Sci. 107 (2009), 427–439.
17. Buyantseva, L.V., et al. Reduction in diisocyanate and non-diisocyanate sensitizer-induced occupational asthma in Ontario. J. Occup. Environ. Med. 53 (2011), 420–426.
18. Chipinda, I., et al. Haptenation: chemical reactivity and protein binding. J. Allergy (Cairo), 2011, 2011, 839682.
19. Cooper, A., et al. Prediction of efficacious inhalation lung doses via the use of in silico lung retention quantitative structure-activity relationship models and in vitro potency screens. Drug Metab. Dispos. 38 (2010), 2218–2225.
20. de Groene, G.J., et al. Workplace interventions for treatment of occupational asthma: a Cochrane systematic review. Occup. Environ. Med. 69 (2012), 373–374.
21. De Jong, W.H., et al. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology 261 (2009), 103–111.
22. Dearman, R.J., et al. Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens. Immunology 86 (1995), 545–550.
23. dos Santos, G.G., et al. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 236 (2009), 372–382.
24. Dumas, O., et al. Occupational exposure to cleaning products and asthma in hospital workers. Occup. Environ. Med. 69 (2012), 883–889.
25. ECHA, Guidance on the Application of the CLP Criteria – Guidance to Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging (CLP) of Substances and Mixtures. 2013 Version 4.0. November 2013 http://echa.europa.eu/documents/10162/13562/clp_en.pdf.
26. ECHA, Identification of Substances as SVHCs Due to Equivalent Level of Concern to CMRs (Article 57(f)) – Sensitisers as an Example. 2013 http://echa.europa.eu/documents/10162/19126370/dp_sensitisers_final_en.pdf (accessed 03.03.15.).
27. Enoch, S.J., et al. Electrophilic reaction chemistry of low molecular weight respiratory sensitizers. Chem. Res. Toxicol. 22 (2009), 1447–1453.
28. Enoch, S.J., et al. Mechanistic category formation for the prediction of respiratory sensitization. Chem. Res. Toxicol. 23 (2010), 1547–1555.
29. Enoch, S.J., et al. Development of mechanism-based structural alerts for respiratory sensitization hazard identification. Chem. Res. Toxicol. 25 (2012), 2490–2498.
30. Haenen, S., et al. Proteome analysis of multiple compartments in a mouse model of chemical-induced asthma. J. Proteome Res. 9 (2010), 5868–5876.
31. Hermanns, M.I., et al. An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction. J. R. Soc. Interface 7:Suppl. 1 (2010), S41–S54.
32. Holsapple, M.P., et al. Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 91 (2006), 4–13.
33. Jaworska, J., et al. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice. J. Appl. Toxicol. 33 (2013), 1353–1364.
34. Jeong, H., et al. Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J. Korean Med. Sci. 20 (2005), 579–585.
35. Johansson, H., et al. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics, 12, 2011, 399.
36. Kimber, I., et al. Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM workshop 60. Altern. Lab. Anim. 35 (2007), 243–265.
37. Kimber, I., Dearman, R.J., Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 181–182 (2002), 311–315.
38. Kimber, I., Dearman, R.J., What makes a chemical a respiratory sensitizer?. Curr. Opin. Allergy Clin. Immunol. 5 (2005), 119–124.
39. Kimber, I., et al. Chemical respiratory allergy: reverse engineering an adverse outcome pathway. Toxicology 318 (2014), 32–39.
40. Kimber, I., et al. Chemical respiratory allergy, IgE and the relevance of predictive test methods: a commentary. Hum. Exp. Toxicol. 17 (1998), 537–540.
41. Kogevinas, M., et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 370 (2007), 336–341.
42. Kuper, C.F., et al. Molecular characterization of trimellitic anhydride-induced respiratory allergy in Brown Norway rats. Toxicol. Pathol. 36 (2008), 985–998.
43. Kuper, C.F., et al. Oxazolone (OXA) is a respiratory allergen in Brown Norway rats. Toxicology 290 (2011), 59–68.
44. Kuper, C.F., et al. The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology 246 (2008), 213–221.
45. Lalko, J.F., et al. Reactivity of chemical respiratory allergens in the peroxidase peptide reactivity assay. Toxicol In Vitro 27 (2013), 651–661.
46. Larsson, K., et al. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 117 (2006), 156–166.
47. Lauenstein, L., et al. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro 28 (2014), 588–599.
48. Louten, J., et al. Biomarkers of disease and treatment in murine and cynomolgus models of chronic asthma. Biomark Insights 7 (2012), 87–104.
49. Lundberg, K., et al. Transcriptional profiling of human dendritic cell populations and models–unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS One, 8, 2013, e52875.
50. Matsuzaki, J., et al. Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases. Autoimmunity 38 (2005), 369–375.
51. Merget, R., et al. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J. Allergy Clin. Immunol. 105 (2000), 364–370.
52. NIOSH, Work-related Asthma: Most Frequently Reported Agents Associated with Work-related Asthma Cases by State, 2009–2010. National Institute of Occupational Safety and Health, 2014 Available at: http://wwwn.cdc.gov/eworld/Data/Work%20related_asthma_Most_frequently_reported_agents_associated_with_work-related_asthma_cases_by_state_20092010/825 (accessed 19.05.15.).
53. O'Neil, S.E., et al. Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled glucocorticoid treatment. Respir. Res., 12, 2011, 124.
54. OECD, The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding for Proteins. Part 1. Scientific Evidence, vol. 168, 2012, OECD Environment, Health and Safety Publications Series on Testing and Assessment, 1–46.
55. Ouwehand, K., et al. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur. J. Immunol. 38 (2008), 3050–3059.
56. Ouwehand, K., et al. Langerhans cells derived from a human cell line in a full-thickness skin equivalent undergo allergen-induced maturation and migration. Tech. Adv. 90 (2011), 1028–1033.
57. Park, C.S., Rhim, T., Application of proteomics in asthma research. Expert Rev. Proteomics 8 (2011), 221–230.
58. Pauluhn, J., Short-term inhalation toxicity of polyisocyanate aerosols in rats: comparative assessment of irritant-threshold concentrations by bronchoalveolar lavage. Inhal. Toxicol. 14 (2002), 287–301.
59. Pauluhn, J., Brown Norway rat asthma model of diphenylmethane 4,4’-diisocyanate. Inhal. Toxicol. 17 (2005), 729–739.
60. Pauluhn, J., Brown Norway rat asthma model of diphenylmethane-4,4’-diisocyanate (MDI): analysis of the elicitation dose-response relationship. Toxicol. Sci. 104 (2008), 320–331.
61. Pauluhn, J., Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level. Toxicology 319 (2014), 10–22.
62. Pauluhn, J., Analysis of the interrelationship of the pulmonary irritation and elicitation thresholds in rats sensitized with 1,6-hexamethylene diisocyanate (HDI). Inhal. Toxicol. 21 (2015), 191–206.
63. Pauluhn, J., Mohr, U., Experimental approaches to evaluate respiratory allergy in animal models. Exp. Toxicol. Pathol. 56 (2005), 203–234.
64. Pauluhn, J., Poole, A., Brown Norway rat asthma model of diphenylmethane-4,4’-diisocyanate (MDI): determination of the elicitation threshold concentration of after inhalation sensitization. Toxicology 281 (2011), 15–24.
65. Roggen, E.L., Application of the acquired knowledge and implementation of the Sens-it-iv toolbox for identification and classification of skin and respiratory sensitizers. Toxicol In Vitro 27 (2013), 1122–1126.
66. Roggen, E.L., In vitro approaches for detection of chemical sensitization. Basic Clin. Pharmacol. Toxicol. 115 (2014), 32–40.
67. Selgrade, M.K., et al. Decision trees for evaluating skin and respiratory sensitizing potential of chemicals in accordance with European regulations. Regul. Toxicol. Pharmacol. 63 (2012), 371–380.
68. Siracusa, A., et al. Occupational anaphylaxis - an EAACI task force consensus statement. Allergy 70 (2015), 141–152.
69. Sircar, G., et al. Allergic asthma biomarkers using systems approaches. Front. Genet., 4, 2014, 308.
70. Smith, P.K., Harper, J.I., Serine proteases, their inhibitors and allergy. Allergy 61 (2006), 1441–1447.
71. Steliarova-Foucher, E., et al. The European Cancer Observatory: a new data resource. Eur. J. Cancer 51 (2015), 1131–1143.
72. Tan, J.K., O'Neill, H.C., Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol. 78 (2005), 319–324.
73. Tarlo, S.M., et al. Diagnosis and management of work-related asthma: American College of chest physicians consensus statement. Chest 134 (2008), 1S–41S.
74. Tarlo, S.M., Lemiere, C., Occupational asthma. N. Engl. J. Med. 370 (2014), 640–649.
75. Toren, K., Blanc, P.D., Asthma caused by occupational exposures is common – a systematic analysis of estimates of the population-attributable fraction. BMC Pulm. Med., 9, 2009, 7.
76. US National Research Council, Toxicity Testing in the 21st Century: a Vision and a Strategy. 2007, The National Academies Press, Washington, DC.
77. van Triel, J.J., et al. Allergic inflammation in the upper respiratory tract of the rat upon repeated inhalation exposure to the contact allergen dinitrochlorobenzene (DNCB). Toxicology 269 (2010), 73–80.
78. van Triel, J.J., et al. The respiratory allergen glutaraldehyde in the local lymph node assay: sensitization by skin exposure, but not by inhalation. Toxicology 279 (2011), 115–122.
79. Vandebriel, R.J., et al. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol. Appl. Pharmacol. 162 (2000), 77–85.
80. Vandenplas, O., et al. Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement. Eur. Respir. J. 43 (2014), 1573–1587.
81. Vandenplas, O., et al. Eaaci position paper: irritant-induced asthma. Allergy 69 (2014), 1141–1153.
82. WHO, IPCS Harmonization Project Document No. 10-Guidance for Immunotoxicity Risk Assessment for Chemicals. 2012, WHO Document Production Services, Geneva, Switzerland.
83. Wills-Karp, M., et al. New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol. 3 (2010), 104–110.
84. Zhang, L., et al. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J. Proteome Res. 8 (2009), 1631–1638.